Koesten Hirschmann & Crabtree’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100
Closed -$147 70
2025
Q3
$147 Hold
100
﹤0.01% 242
2025
Q2
$178 Hold
100
﹤0.01% 315
2025
Q1
$146 Hold
100
﹤0.01% 202
2024
Q4
$153 Buy
+100
New +$163 ﹤0.01% 190

Other funds holding CGEN

Koesten Hirschmann & Crabtree's CGEN Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Compugen (CGEN) in Q4 2025, closing a stake of 100 shares — an estimated $147 sold.

Koesten Hirschmann & Crabtree first reported a position in CGEN in Q4 2024 and held it in 4 quarters. The position peaked at $178 in Q2 2025. 72 funds tracked by Wall St. Rank hold CGEN as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Compugen position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 100 Compugen shares in Q4 2025, an estimated $147.
  • Koesten Hirschmann & Crabtree first reported a position in Compugen in Q4 2024 and held it in 4 quarters.
  • Koesten Hirschmann & Crabtree's Compugen position peaked at $178 in Q2 2025.
  • 72 funds tracked by Wall St. Rank held Compugen as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.